| GTO ID | GTC2876 |
| Trial ID | NCT05164666 |
| Disease | Solid Tumor |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TAK-103 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Study of TAK-103 in Adult With Solid Tumors |
| Year | 2021 |
| Country | Japan |
| Company sponsor | Kagehara Hideaki |
| Other ID(s) | jRCT2033210463 |
| Cohort 1 | |||||||||
|
|||||||||